US health regulators have approved an artificially intelligent medical device that can identify disease without doctor’s attention. The device-IDx-DR, is designed to detect the most common cause of vision loss among people living with diabetes. The in-built camera takes a picture of the patient’s eye, which is assessed by an algorithm to determine whether there are signs of diabetic retinopathy.

IDx-DR will be used to detect diabetic retinopathy, in which high levels of blood sugar lead to damage in the blood vessels of the retina and vision loss. IDx-DR program uses Artificial Intelligent AI software to analyze images of the eye taken with a retinal camera.

The software indicates that the patient either has more than mild diabetic retinopathy and should be referred to eye care professional for treatment, or is ‘negative’ for more than mild diabetic retinopathy and should be rescreened in 12 months.

In a clinical trial, IDx-DR was able to correctly identify the presence of more than mild diabetic retinopathy 87.4 percent of the time and identify those who did not have more than mild disease 89.5 percent of the time.
[url]haleplushearty.org[/url]